Role of miRNAs in muscle stem cell biology: Proliferation, differentiation and death

Current Pharmaceutical Design

Volumn 18, Issue 13, 2012, Pages 1718-1729

  Crippa, Stefania ^b   Cassano, Marco ^b   Sampaolesi, Maurilio ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cardiac and muscle myogenesis; miRNAs; Stem cells

Indexed keywords

MICRORNA; MYOSIN;

APOPTOSIS; BIOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DNA SEQUENCE; HEART DEVELOPMENT; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; STEM CELL;

ADULT; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICRORNAS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; STEM CELLS;

EID: 84860130921     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799859620     Document Type: Review

References (113)

1. Megraw M, Hatzigeorgiou AG. MicroRNA promoter analysis. Methods Mol Biol 592: 149-161.
2. Borchert GM, Lanier W, Davidson BL. RNA polymerase III tran-scribes human microRNAs. Nat Struct Mol Biol 2006; 13: 1097-1101.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
4. Yao B, Li S, Jung HM, et al. Divergent GW182 functional domains in the regulation of translational silencing. Nucleic Acids Res 39: 2534-2547.
5. Rossi JJ. RNAi and the P-body connection. Nat Cell Biol 2005; 7: 643-644.
6. Chatterjee S, Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 2009; 461: 546-549.
7. Ramachandran V, Chen X. Degradation of microRNAs by a family of exoribonucleases in Arabidopsis. Science 2008; 321: 1490-1492.
8. Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452.
9. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
10. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3: e3694.
11. Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13: 423-433.
12. Hake S. MicroRNAs: a role in plant development. Curr Biol 2003; 13: R851-R852.
13. Chen X. A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development. Science 2004; 303: 2022-2025.
14. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of mi-croRNA-target recognition. PLoS Biol 2005; 3: e85.
15. Wu H, Ye C, Ramirez D, Manjunath N. Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA. PLoS One 2009; 4: e7566.
16. Doench JG, Petersen CP, Sharp PA. Sirnas can function as miR-NAs. Genes Dev 2003; 17: 438-442.
17. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: e179.
18. Landthaler M, Gaidatzis D, Rothballer A, et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. Rna 2008; 14: 2580-2596.
19. Ameres SL, Martinez J, Schroeder R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 2007; 130: 101-112.
20. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogene-sis. Nature 2005; 436: 214-220.
21. Nagata S. Apoptosis and autoimmune diseases. Ann N Y Acad Sci 2010; 1209: 10-16.
22. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an anti-apoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-6033.
23. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328-14336.
24. Wang Y, Lee CG. MicroRNA and cancer-focus on apoptosis. Journal of cellular and molecular medicine 2009; 13: 12-23.
25. Cimmino A, Calin GA, Fabbri M, et al. Mir-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-13949.
26. Franke TF, Hornik CP, Segev L, et al. PI3K/Akt and apoptosis: size matters. Oncogene 2003; 22: 8983-8998.
27. Small EM, O'Rourke JR, Moresi V, et al. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci USA 2010; 107: 4218-4223.
28. Park SY, Lee JH, Ha M, et al. Mir-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 2009; 16: 23-29.
29. Fish JE, Santoro MM, Morton SU, et al. Mir-126 regulates angio-genic signaling and vascular integrity. Dev Cell 2008; 15: 272-284.
30. Foley NH, Bray IM, Tivnan A, et al. MicroRNA-184 inhibits neu-roblastoma cell survival through targeting the serine/threonine kinase AKT2. Molecular cancer 2010; 9: 83.
31. Bernstein E, Kim SY, Carmell MA, et al. Dicer is essential for mouse development. Nat Genet 2003; 35: 215-217.
32. Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 2009; 10: 116-125.
33. Murchison EP, Partridge JF, Tam OH, et al. Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 2005; 102: 12135-12140.
34. Kanellopoulou C, Muljo SA, Kung AL, et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 2005; 19: 489-501.
35. Sinkkonen L, Hugenschmidt T, Berninger P, et al. MicroRNAs control de novo DNA methylation through regulation of transcrip-tional repressors in mouse embryonic stem cells. Nat Struct Mol Biol 2008; 15: 259-267.
36. Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463: 621-626.
37. Tay Y, Zhang J, Thomson AM, et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008; 455: 1124-1128.
38. Rosa A, Spagnoli FM, Brivanlou AH. The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell 2009; 16: 517-527.
39. Ren XP, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009; 119: 2357-2366.
40. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890-1900.
41. Ransom J, Srivastava D. The genetics of cardiac birth defects. Semin Cell Dev Biol 2007; 18: 132-139.
42. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006; 126: 1037-1048.
43. Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116: 258-267.
44. da Costa Martins PA, Bourajjaj M, Gladka M, et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 2008; 118: 1567-1576.
45. Zhang X, Azhar G, Helms SA, Wei JY. Regulation of cardiac microRNAs by serum response factor. J Biomed Sci 18: 15.
46. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228-233.
47. Itoh M, Kim CH, Palardy G, et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell 2003; 4: 67-82.
48. Boxer LM, Prywes R, Roeder RG, Kedes L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Mol Cell Biol 1989; 9: 515-522.
49. Niu Z, Li A, Zhang SX, Schwartz RJ. Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol 2007; 19: 618-627.
50. Liu N, Williams AH, Kim Y, et al. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci USA 2007; 104: 20844-20849.
51. Schlesinger J, Schueler M, Grunert M, et al. The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet 7: e1001313.
52. Sepulveda JL, Belaguli N, Nigam V, et al. GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol Cell Biol 1998; 18: 3405-3415.
53. Chen JF, Murchison EP, Tang R, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 2008; 105: 2111-2116.
54. Lien CL, McAnally J, Richardson JA, Olson EN. Cardiac-specific activity of an Nkx2-5 enhancer requires an evolutionarily conserved Smad binding site. Dev Biol 2002; 244: 257-266.
55. Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 2007; 32: 189-197.
56. Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007; 13: 486-491.
57. Xiao J, Luo X, Lin H, et al. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007; 282: 12363-12367.
58. Luo X, Lin H, Pan Z, et al. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 2008; 283: 20045-20052.
59. Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007; 120: 3045-3052.
60. Weiss A, Leinwand LA. The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol 1996; 12: 417-439.
61. Morkin E. Control of cardiac myosin heavy chain gene expression. Microsc Res Tech 2000; 50: 522-531.
62. Ojamaa K, Kenessey A, Klein I. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 2000; 141: 2139-2144.
63. van Rooij E, Sutherland LB, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007; 316: 575-579.
64. Callis TE, Pandya K, Seok HY, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009; 119: 2772-2786.
65. Vadaszova A, Zacharova G, Machacova K, et al. Influence of thyroid status on the differentiation of slow and fast muscle pheno-types. Physiol Res 2004; 53 Suppl 1: S57-S61.
66. van Rooij E, Quiat D, Johnson BA, et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009; 17: 662-673.
67. Wang JX, Jiao JQ, Li Q, et al. Mir-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 17: 71-78.
68. Lu J, McKinsey TA, Zhang CL, Olson EN. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 2000; 6: 233-244.
69. McKinsey TA, Zhang CL, Lu J, Olson EN. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000; 408: 106-111.
70. McCarthy JJ. MicroRNA-206: the skeletal muscle-specific myo-miR. Biochim Biophys Acta 2008; 1779: 682-691.
71. Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 2006; 34: 5863-5871.
72. Williams AH, Valdez G, Moresi V, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009; 326: 1549-1554.
73. Rosenberg MI, Georges SA, Asawachaicharn A, et al. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol 2006; 175: 77-85.
74. Clop A, Marcq F, Takeda H, et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006; 38: 813-818.
75. Crist CG, Montarras D, Pallafacchina G, et al. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc Natl Acad Sci USA 2009; 106: 13383-13387.
76. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, et al. The mi-croRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 2006; 8: 278-284.
77. Cacchiarelli D, Incitti T, Martone J, et al. Mir-31 modulates dys-trophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO reports 2011; 12: 136-141.
78. Gumerson JD, Kabaeva ZT, Davis CS, et al. Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury. Am J Physiol Cell Physiol 299: C1430-C1440.
79. McKinsey TA, Olson EN. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 2005; 115: 538-546.
80. van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006; 103: 18255-18260.
81. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007; 13: 613-618.
82. Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007; 31: 367-373.
83. Bruneau BG. Developmental biology: tiny brakes for a growing heart. Nature 2005; 436: 181-182.
84. Sayed D, Hong C, Chen IY, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007; 100: 416-424.
85. Brown JH, Del Re DP, Sussman MA. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res 2006; 98: 730-742.
86. Condorelli G, Drusco A, Stassi G, et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 2002; 99: 12333-12338.
87. van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008; 105: 13027-13032.
88. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibro-blasts. Nature 2008; 456: 980-984.
89. Duisters RF, Tijsen AJ, Schroen B, et al. Mir-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009; 104: 170-178, 6p following 178.
90. Cheng Y, Zhu P, Yang J, et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87: 431-439.
91. Rane S, He M, Sayed D, et al. Downregulation of miR-199a derep-resses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009; 104: 879-886.
92. Couly GF, Coltey PM, Le Douarin NM. The developmental fate of the cephalic mesoderm in quail-chick chimeras. Development 1992; 114: 1-15.
93. Noden DM. The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues. Dev Biol 1983; 96: 144-165.
94. Tirosh-Finkel L, Elhanany H, Rinon A, Tzahor E. Mesoderm progenitor cells of common origin contribute to the head musculature and the cardiac outflow tract. Development 2006; 133: 1943-1953.
95. Dowell JD, Rubart M, Pasumarthi KB, et al. Myocyte and myo-genic stem cell transplantation in the heart. Cardiovasc Res 2003; 58: 336-350.
96. Van Meter CH, Jr., Claycomb WC, Delcarpio JB, et al. Myoblast transplantation in the porcine model: a potential technique for myocardial repair. J Thorac Cardiovasc Surg 1995; 110: 1442-1448.
97. SoRelle R. Myoblast transplant to heart attempted. Circulation 2000; 102: E9030-E9031.
98. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-80.
99. Menasche P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117: 1189-1200.
100. Gavira JJ, Herreros J, Perez A, et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 2006; 131: 799-804.
101. Sabourin LA, Girgis-Gabardo A, Seale P, et al. Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J Cell Biol 1999; 144: 631-643.
102. Winitsky SO, Gopal TV, Hassanzadeh S, et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardio-myocytes in vitro. PLoS Biol 2005; 3: e87.
103. Tamaki T, Okada Y, Uchiyama Y, et al. Skeletal muscle-derived CD34+/45- and CD34-/45- stem cells are situated hierarchically upstream of Pax7+ cells. Stem Cells Dev 2008; 17: 653-667.
104. Crippa S, Cassano M, Messina G, et al. Mir669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors. J Cell Biol 193: 1197-1212.
105. Gentner B, Schira G, Giustacchini A, et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009; 6: 63-66.
106. Haraguchi T, Ozaki Y, Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 2009; 37: e43.
107. Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet 2007; 8: 573-587.
108. Stefania Crippa MC, Graziella Messina, Daniela Galli, et al. Mir669a and miR669q prevent skeletal muscle differentiation in post-natal cardiac progenitors. Journal of Cell Biology 2011; (in press).
109. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-242.
110. Kazuki Y, Hoshiya H, Kai Y, et al. Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome. Gene therapy 2008; 15: 617-624.
111. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
112. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profile, profile, profile. International journal of cancer. Journal international du cancer 2008; 122: 969-977.
113. Hotarkova S, Hermanova M, Povysilova V, et al. Demonstration of MyoD1 expression in oncocytic cardiomyopathy: report of two cases and review of the literature. Pathol Res Pract 2004; 200: 59-65.